Literature DB >> 20219621

Isolated polycystic liver disease.

Qi Qian1.   

Abstract

Isolated polycystic liver disease (PCLD) is an autosomal dominant disease with genetic and clinical heterogeneity. Apart from liver cysts, it exhibits few extrahepatic manifestations, and the majority of patients with this condition are asymptomatic or subclinical. However, a small fraction of these patients develop acute liver cyst-related complications and/or massive cystic liver enlargement, causing morbidity and mortality. Currently, the management for symptomatic PCLD is centered on palliating symptoms and treating complications. 2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2010        PMID： 20219621      PMCID： PMC2837599          DOI： 10.1053/j.ackd.2009.12.005

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN： 1548-5595            Impact factor:   3.620


  75 in total

Review 1.  Protein translocons: multifunctional mediators of protein translocation across membranes.

Authors:  Danny J Schnell; Daniel N Hebert
Journal:  Cell       Date:  2003-02-21       Impact factor: 41.582

Review 2.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

3.  Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation.

Authors:  Thomas Schnelldorfer; Vicente E Torres; Shaheen Zakaria; Charles B Rosen; David M Nagorney
Journal:  Ann Surg       Date:  2009-07       Impact factor: 12.969

4.  Long-term results of multiple minocycline hydrochloride injections for the treatment of symptomatic solitary hepatic cyst.

Authors:  Hiroshi Yoshida; Masahiko Onda; Takashi Tajiri; Yasuo Arima; Yasuhiro Mamada; Nobuhiko Taniai; Koho Akimaru
Journal:  J Gastroenterol Hepatol       Date:  2003-05       Impact factor: 4.029

5.  Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease.

Authors:  Joost P H Drenth; Rene H M te Morsche; Renate Smink; Juan S Bonifacino; Jan B M J Jansen
Journal:  Nat Genet       Date:  2003-02-10       Impact factor: 38.330

6.  Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys.

Authors:  Tamio Yamaguchi; Shizuko Nagao; Darren P Wallace; Franck A Belibi; Benjamin D Cowley; Jill C Pelling; Jared J Grantham
Journal:  Kidney Int       Date:  2003-06       Impact factor: 10.612

Review 7.  Cholangiociliopathies: genetics, molecular mechanisms and potential therapies.

Authors:  Tatyana Masyuk; Anatoliy Masyuk; Nicholas LaRusso
Journal:  Curr Opin Gastroenterol       Date:  2009-05       Impact factor: 3.287

8.  Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease.

Authors:  Airong Li; Sonia Davila; Laszlo Furu; Qi Qian; Xin Tian; Patrick S Kamath; Bernard F King; Vicente E Torres; Stefan Somlo
Journal:  Am J Hum Genet       Date:  2003-01-15       Impact factor: 11.025

9.  Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor.

Authors:  A Mancino; M G Mancino; S S Glaser; G Alpini; A Bolognese; L Izzo; H Francis; P Onori; A Franchitto; S Ginanni-Corradini; E Gaudio; D Alvaro
Journal:  Dig Liver Dis       Date:  2008-04-18       Impact factor: 4.088

10.  Intravascular embolization therapy in a patient with an enlarged polycystic liver.

Authors:  Yoshifumi Ubara; Ryouji Takei; Jyunichi Hoshino; Tetsuo Tagami; Naoki Sawa; Masafumi Yokota; Hideyuki Katori; Fumi Takemoto; Shigeko Hara; Kenmei Takaichi
Journal:  Am J Kidney Dis       Date:  2004-04       Impact factor: 8.860
View more
  24 in total

1.  Hepatorenal findings in obligate heterozygotes for autosomal recessive polycystic kidney disease.

Authors:  Meral Gunay-Aygun; Baris I Turkbey; Joy Bryant; Kailash T Daryanani; Maya Tuchman Gerstein; Katie Piwnica-Worms; Peter Choyke; Theo Heller; William A Gahl
Journal:  Mol Genet Metab       Date:  2011-09-08       Impact factor: 4.797

Review 2.  Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases.

Authors:  Bassam Abu-Wasel; Caolan Walsh; Valerie Keough; Michele Molinari
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

Review 3.  Evaluation of hepatic cystic lesions.

Authors:  Marten A Lantinga; Tom J G Gevers; Joost P H Drenth
Journal:  World J Gastroenterol       Date:  2013-06-21       Impact factor: 5.742

4.  Polycystic liver disease.

Authors:  Rodrigo Nazário Leão; Raquel Salustio; José Vaz Ribeiro
Journal:  BMJ Case Rep       Date:  2014-01-17

Review 5.  Diagnosis and management of polycystic liver disease.

Authors:  Tom J G Gevers; Joost P H Drenth
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-01-08       Impact factor: 46.802

Review 6.  Current management of noninfectious hepatic cystic lesions: A review of the literature.

Authors:  Francisco Igor Macedo
Journal:  World J Hepatol       Date:  2013-09-27

7.  Liver findings in patients with Carney complex, germline PRKAR1A pathogenic variants, and link to cardiac myxomas.

Authors:  Amit Tirosh; Ahmed Hamimi; Fabio Faucz; Genya Aharon-Hananel; Phaedon D Zavras; Belen Bonella; Adi Auerbach; David Gillis; Charalampos Lyssikatos; Elena Belyavskaya; Constantine A Stratakis; Ahmed M Gharib
Journal:  Endocr Relat Cancer       Date:  2020-06       Impact factor: 5.678

8.  Whole-exome sequencing reveals LRP5 mutations and canonical Wnt signaling associated with hepatic cystogenesis.

Authors:  Wybrich R Cnossen; René H M te Morsche; Alexander Hoischen; Christian Gilissen; Melissa Chrispijn; Hanka Venselaar; Soufi Mehdi; Carsten Bergmann; Joris A Veltman; Joost P H Drenth
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-24       Impact factor: 11.205

9.  Polycystic diseases in visceral organs.

Authors:  Shakila Abdul-Majeed; Surya M Nauli
Journal:  Obstet Gynecol Int       Date:  2011-12-26

10.  Neuroendocrine tumor in the liver of a patient with isolated polycystic liver disease: A case report and review of the literature.

Authors:  Konstantinos Koutsampasopoulos; Elisavet Antoniadou; Stavros Zoutis; Grigorios Iacovidis; Olga Burova; Antonios Taplidis
Journal:  Oncol Lett       Date:  2013-03-06       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.